Adderall, the popular medication prescribed for people diagnosed with attention deficit hyperactivity disorder (ADHD) and narcolepsy, has been in short supply in the United States since October 2022.
Months after the Federal Drug Administration (FDA) first announced the nationwide shortage, it’s still unclear when it’ll be resolved.